NUWE — Nuwellis, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1506492 ·
Last close
$0.78
Market Cap
$2.48M
52W High
$172.90
52W Low
$0.71
ADV30
3,194,070
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,969,000 | 1,498,000 | -3,169,000 | -4,828,000 | 9,126,000 | 3,922,000 | 11,171,000 |
| Mar 2026 | 2,403,000 | 1,684,000 | -4,568,000 | -4,541,000 | 6,961,000 | 2,083,000 | 4,292,000 |
| Dec 2025 | 2,424,000 | 1,654,000 | -2,443,000 | -2,422,000 | 6,118,000 | 1,085,000 | 3,488,000 |
| Sep 2025 | 2,217,000 | 1,445,000 | -2,697,000 | 468,000 | 7,984,000 | 3,094,000 | 4,070,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,386,000
Investing CF
$-374,000
Financing CF
$11,335,000
CapEx
$-241,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2239.85
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-320,853,000
Inventory
$1,779,000
Receivables
$1,559,000
ST Investments
—
EBIT TTM
$-8,518,000
Pretax Income TTM
$-19,044,000
Interest Exp TTM
$10,553,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,013,000
EBITDA
$-12,725,000
Free Cash Flow
$-11,442,250
Enterprise Value
$-889,017
Total Cash
$3,922,000
Total Debt
$200,000
Shares Out
3,175,134
Trailing EPS
$2548.34
Book Value
$-3.58
ROE
-609.4%
ROA
-87.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,270,000 | -11,106,000 | -17,521,000 | 6,118,000 | 3,488,000 | 2,630,000 | -10,810,000 |
| Dec 2024 | 8,740,000 | -10,988,000 | -11,165,000 | 9,864,000 | 3,334,000 | 6,530,000 | -9,591,000 |
| Dec 2023 | 8,864,000 | -17,630,000 | -20,209,000 | 9,770,000 | 6,559,000 | 3,211,000 | -17,937,000 |
| Dec 2022 | 8,543,000 | -17,171,000 | -14,525,000 | 24,673,000 | 12,316,000 | 12,357,000 | -15,149,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.59
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IVF | INVO Fertility, Inc. | $2.37M | $0.94 | — |
| ITOC | iTonic Holdings Ltd | $2.73M | $0.29 | — |
| VYCO | VYCOR MEDICAL INC | $2.24M | $0.07 | — |
| XAIR | Beyond Air, Inc. | $2.81M | $2.85 | — |
| VVOS | Vivos Therapeutics, Inc. | $2.84M | $0.14 | — |
News headlines (Yahoo Finance, 1h cache)
Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue Opportunity
2026-09-17 14:23 · Yahoo
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
2026-09-17 12:30 · Yahoo
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
2026-09-16 12:30 · Yahoo
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
2026-08-25 12:30 · Yahoo
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...
2026-08-13 23:05 · Yahoo
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
2026-08-13 12:00 · Yahoo
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface
2026-08-11 07:30 · Yahoo
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2026-07-31 12:39 · Yahoo
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
2026-07-30 12:00 · Yahoo
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
2026-07-27 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.